On May 23, 2025, GRI Bio, Inc. filed a prospectus to increase the number of shares available for sale under an existing agreement, raising the total potential offering to about $1.76 million, excluding previous sales of approximately $4.55 million. This action indicates ongoing capital-raising efforts by the company.